WDTC1
Basic information
Region (hg38): 1:27234632-27308636
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the WDTC1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 23 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 0 | 4 |
Variants in WDTC1
This is a list of pathogenic ClinVar variants found in the WDTC1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-27261059-C-T | not specified | Uncertain significance (Apr 16, 2024) | ||
1-27261060-G-A | Benign (Mar 29, 2018) | |||
1-27261086-T-A | not specified | Uncertain significance (Dec 01, 2022) | ||
1-27261088-C-T | not specified | Uncertain significance (Apr 26, 2024) | ||
1-27263159-G-T | not specified | Uncertain significance (Apr 19, 2024) | ||
1-27263177-G-A | not specified | Uncertain significance (Dec 17, 2023) | ||
1-27263242-G-T | Benign (Apr 17, 2018) | |||
1-27287798-G-A | not specified | Uncertain significance (Apr 01, 2024) | ||
1-27292246-T-G | not specified | Uncertain significance (Dec 27, 2022) | ||
1-27294617-G-T | not specified | Uncertain significance (Aug 12, 2021) | ||
1-27294619-G-C | not specified | Uncertain significance (Jan 10, 2023) | ||
1-27296341-T-A | not specified | Uncertain significance (Jul 06, 2021) | ||
1-27296373-C-T | Benign (May 17, 2018) | |||
1-27297076-C-T | Benign (Dec 11, 2017) | |||
1-27297099-A-G | not specified | Uncertain significance (Apr 13, 2023) | ||
1-27297128-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
1-27297129-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
1-27297135-C-T | not specified | Uncertain significance (Sep 01, 2021) | ||
1-27297968-G-C | not specified | Uncertain significance (Oct 22, 2021) | ||
1-27298061-C-A | not specified | Uncertain significance (Feb 27, 2024) | ||
1-27301423-G-A | not specified | Uncertain significance (Jun 16, 2024) | ||
1-27303648-C-T | not specified | Uncertain significance (Sep 20, 2023) | ||
1-27303656-C-T | not specified | Uncertain significance (Aug 30, 2021) | ||
1-27303662-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
1-27303669-C-T | not specified | Uncertain significance (Aug 10, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
WDTC1 | protein_coding | protein_coding | ENST00000361771 | 15 | 74104 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.000849 | 125738 | 0 | 4 | 125742 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.81 | 209 | 432 | 0.484 | 0.0000275 | 4457 |
Missense in Polyphen | 42 | 168.11 | 0.24983 | 1679 | ||
Synonymous | 0.638 | 162 | 173 | 0.938 | 0.0000110 | 1323 |
Loss of Function | 4.90 | 3 | 33.7 | 0.0891 | 0.00000175 | 374 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000677 | 0.0000544 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.00000879 | 0.00000879 |
Middle Eastern | 0.0000677 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex. {ECO:0000269|PubMed:16964240}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.149
Intolerance Scores
- loftool
- 0.0872
- rvis_EVS
- -0.44
- rvis_percentile_EVS
- 24.46
Haploinsufficiency Scores
- pHI
- 0.987
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.529
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.985
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Wdtc1
- Phenotype
- growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hearing/vestibular/ear phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;in utero embryonic development;glucose metabolic process;regulation of cell size;protein ubiquitination;cellular response to insulin stimulus;multicellular organism growth;negative regulation of catalytic activity;post-translational protein modification;negative regulation of fatty acid biosynthetic process;cellular chemical homeostasis
- Cellular component
- nucleoplasm;cytosol
- Molecular function
- enzyme inhibitor activity;protein binding;histone binding;histone deacetylase binding